✦ LIBER ✦

Isothiazolopyrimidines and Isoxazolopyrimidines as Novel Multi-Targeted Inhibitors of Receptor Tyrosine Kinases.

✍ Scribed by Zhiqin Ji; et al. et al.

Publisher: John Wiley and Sons
Year: 2006
Weight: 26 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200651154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel azulene-based derivatives as poten

Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors

✍ Chih-Hung Chen; On Lee; Chung-Niang Yao; Meng-Yun Chuang; Yow-Lone Chang; May-Hu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 579 KB

A series of azulene-based derivatives were synthesized as potent inhibitors for receptor tyrosine kinases such as FMS-like tyrosine kinase 3 (FLT-3). Systematic side chain modification of prototype 1a was carried out through SAR studies. Analogue 22 was identified from this series and found to be on

Preclinical anti-angiogenesis and anti-t

Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor

✍ Dongchun Wang; Feng Tang; Sen Wang; Zhenzhou Jiang; Luyong Zhang 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 563 KB

Discovery of 4-Benzylamino-Substituted α

Discovery of 4-Benzylamino-Substituted α-Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors

✍ Dr. Martin Krug; Dr. Kanin Wichapong; German Erlenkamp; Prof. Dr. Wolfgang Sippl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 1 views

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d

Furo[2,3-d]pyrimidines and Oxazolo[5,4-d]pyrimidines as Inhibitors of Receptor Tyrosine Kinases (RTK)

✍ Andreas Martin-Kohler; Jörg Widmer; Guido Bold; Thomas Meyer; Urs Séquin; Peter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 German ⚖ 276 KB 👁 1 views

## Abstract Receptor tyrosine kinases such as VEGFR2 (vascular endothelial growth factor receptor 2, KDR) or EGFR (epidermal growth factor receptor) play crucial roles in a variety of diseases, such as cancer. Recently, some pyrrolopyrimidines were shown to be potent EGFR inhibitors. Therefore, new

Inhibitors of Epidermal Growth Factor Re

Inhibitors of Epidermal Growth Factor Receptor Tyrosine Kinase: Novel C-5 Substituted Anilinoquinazolines Designed to Target the Ribose Pocket.

✍ Jason G. Kettle; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Evaluation of the safety and pharmacokin

Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo–fetal development in rats and rabbits

✍ S. Patyna; J. Haznedar; D. Morris; K. Freshwater; G. Peng; J. Sukbuntherng; G. C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views